Loading...
XNAS
PRVA
Market cap3.43bUSD
Jul 09, Last price  
27.77USD
1D
2.06%
1Q
24.14%
IPO
-23.54%
Name

Privia Health Group Inc

Chart & Performance

D1W1MN
XNAS:PRVA chart
P/E
152.68
P/S
1.65
EPS
0.18
Div Yield, %
Shrs. gr., 5y
4.04%
Rev. gr., 5y
21.04%
Revenues
2.12b
+22.26%
657,609,000786,360,000817,075,000966,220,0001,356,660,0001,657,737,0001,736,390,0002,122,842,000
Net income
23m
+59.33%
-3,044,0008,244,00031,244,000-188,230,000-8,585,00023,079,00014,385,00022,919,000
CFO
163m
+49.53%
5,249,00024,358,00038,891,00055,058,00047,196,00080,785,000109,282,000163,404,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.
IPO date
Apr 29, 2021
Employees
964
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT